Yes, increasing levetiracetam from 500 mg to 1 g twice daily is appropriate and recommended when seizures persist.
Recommended Dosing Strategy
The FDA-approved dosing for levetiracetam in adults with partial onset seizures starts at 500 mg twice daily (1000 mg/day total), with dose increases of 1000 mg/day every 2 weeks up to a maximum of 3000 mg/day (1500 mg twice daily). 1 Your proposed increase to 1 g twice daily (2000 mg/day total) falls well within this therapeutic range and represents the standard first dose escalation.
Evidence Supporting Dose Escalation
The evidence strongly supports this dose increase:
Dose-response relationship is well-established: Clinical trials demonstrate that levetiracetam 2000 mg/day achieves responder rates (≥50% seizure reduction) of 31-34%, compared to only 22-33% at 1000 mg/day 2. The highest tested dose of 3000 mg/day achieved responder rates up to 39.8% 2.
Recent meta-analysis confirms dose-dependent efficacy: A 2020 Cochrane review found that for each 1000 mg increase in levetiracetam dose, the odds of achieving ≥50% seizure reduction increased by nearly 40% (OR 1.39,95% CI 1.23-1.58) 3. Notably, the 500 mg/day dose was no more effective than placebo 3.
Real-world data supports escalation in non-responders: A 2020 retrospective study of patients with persistent seizures on baseline levetiracetam doses found that 91.8% showed reduced seizure frequency after dose increases, with 73.8% achieving ≥50% reduction and 21.3% becoming seizure-free 4.
Tolerability at Higher Doses
The safety profile remains favorable at 2000 mg/day: Discontinuation rates due to adverse events ranged only 7-13% across doses, with no dose-related increase in discontinuation 2. The most common side effects—somnolence (13% of patients), dizziness, and headache—are generally mild 3.
Important caveat for children: If treating a pediatric patient, monitor closely for behavioral changes, as 23% of children experienced behavior problems with levetiracetam (RR 1.90) 3. In adults, behavioral changes affect only 1% 3.
Practical Implementation
Follow this escalation protocol:
- Increase from 500 mg to 1000 mg twice daily (your proposed dose)
- Wait 2 weeks to assess response and tolerability
- If seizures persist, consider further escalation to 1500 mg twice daily (3000 mg/day total maximum)
- Titrate gradually rather than rapidly—slower titration improves tolerability 2
Key Clinical Pitfalls to Avoid
- Don't stop at subtherapeutic doses: The evidence shows 500 mg twice daily may be insufficient for many patients 3
- Don't exceed 3000 mg/day: Doses above this provide no additional benefit 1
- Monitor for hyponatremia: Though rare with levetiracetam, check electrolytes if symptoms develop
- Watch for behavioral changes in children: This is the most significant age-related adverse effect 3
The dose increase you're proposing is evidence-based, FDA-approved, and represents standard clinical practice for persistent seizures on levetiracetam 134.